Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
661472-41-9
Purity
95%
Relamorelin has been investigated for the treatment and basic science of Gastroparesis, Gastric Motility, Diabetes Mellitus, Parkinson's Disease, and Chronic Constipation. It is a potent inhibitor of Growth hormone secretagogue receptor type 1, Ki = 0.42 nM.
Properties
Name
Relamorelin
Smiles
NC(=O)C1(CCNCC1)NC(=O)[C@H](CC=2C=CC=CC2)NC(=O)[C@@H](CC3=CNC=4C=CC=CC34)NC(=O)[C@@H](CC5=CSC=6C=CC=CC56)NC(=O)C7CCNCC7
Targets
Please log in to see this information
SDS
H-Inp-(D-Bal)-(D-Trp)-Phe-Apc-NH | relamorelin
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$297
2 mg
$445
5 mg
$890
10 mg
$1543
15 mg
$1869
20 mg
$2196
25 mg
$2670
30 mg
$3145
35 mg
$3620
40 mg
$4095
45 mg
$4391
50 mg
$4688
75 mg
$6230
100 mg
$POA
Quantity
1
Total amount
$ 890
H-Inp-(D-Bal)-(D-Trp)-Phe-Apc-NH | relamorelin
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.